Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients

Results Follow ACTIVATE Study Data In December

 
• By Alaric DeArment
3-D Rendering Red Blood Cells
Agios' trial of mitapivat shows reduction in transfusion burden among patinets with rare anemia. • Source: Shutterstock

More from Business

More from Scrip